Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions
Lung Cancer, 06/29/09
Flores-Staino C et al. - The commercial UroVysion-test can be used to accurately distinguish malignant and reactive cells in effusions, particularly when cytology is inconclusive. The test may also indicate presence of MM.
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of dust exposure and nitrogen oxides on lung function parameters of German coalminers: a longitudinal study applying GEE regression 1974-1998
International Archives of Occupational & Environmental Health, 11/30/09
Procalcitonin: Inflammatory Biomarker for Assessing the Severity of Community-Acquired Pneumonia - A Clinical Observation in Geriatric Patients
Gerontology, 11/30/09
Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON)
British Journal of Cancer, 11/30/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiproliferative effect of exemestane in lung cancer cells
Molecular Cancer, 11/30/09
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: Updated survival analysis of JRB-10
Journal of Clinical Oncology, 11/30/09
Skeletal morbidity in lung cancer patients with bone metastases: Demonstrating the need for early diagnosis and treatment with bisphosphonates
Lung Cancer, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


